后生元抗病毒性肠胃炎实验研究进展  

Experimental research progress in postbiotics against viral gastroenteritis

作　　者：凌健棉 王盼 黎金彩 蔡赐美 周海泳 晏琦 胡文锋[1,2,3] 李雪玲 LING Jianmian;WANG Pan;LI Jincai;CAI Cimei;ZHOU Haiyong;YAN Qi;HU Wenfeng;LI Xueling(Applied Microbiology Laboratory,College of Food Science,South China Agricultural University,Guangzhou 510642,Guangdong,China;Standard Postbiotics(Shenzhen)Co.,Ltd.,Shenzhen 518107,Guangdong,China;Bioforte Biotechnology(Shenzhen)Co.,Ltd.,Shenzhen 518118,Guangdong,China)

机构地区：[1]华南农业大学食品学院应用微生物实验室,广东广州510642 [2]深圳市先达后生元生物科技有限公司,广东深圳518107 [3]生物源生物技术(深圳)股份有限公司,广东深圳518118

出　　处：《微生物学通报》2025年第1期46-59,共14页Microbiology China

基　　金：华南农业大学校企合作横向项目(H230386)。

摘　　要：病毒性肠胃炎是由多种病毒引起的急性传染病。后生元可用于病毒性肠胃炎的预防和治疗,其具体临床可行性和治疗策略仍需进一步探究。本文详细介绍了国内外关于后生元组分抗轮状病毒、诺如病毒性肠胃炎及其作用机制的最新研究进展,分析后生元抗肠道病毒的研究现状及未来研究方向,有利于后生元在肠道病毒防治应用的研究。Viral gastroenteritis is an acute infectious disease caused by multiple different viruses.Postbiotics can be used for the prevention and treatment of viral gastroenteritis,and the specific clinical feasibility and treatment strategy remain to be studied.This article reviews the latest research progress in the application and mechanism of postbiotic components in treating gastroenteritis caused by rotavirus and norovirus and discusses the current status and future research directions of postbiotics in inhibiting enteroviruses.This review is conducive to the research on the application of postbiotics in the prevention and treatment of enteroviruses.

关 键 词：后生元 病毒性肠胃炎 轮状病毒 诺如病毒 

分 类 号：R512.5[医药卫生—内科学]